Valuation: Implantica AG

Market Cap 1.45B 1.69B 1.35B 1.24B 2.33B 162B 2.36B 16.01B 6.24B 81.25B 6.35B 6.21B 269B P/E 2026 *
-16x
P/E 2027 * -13.9x
Enterprise Value 1.42B 1.66B 1.33B 1.22B 2.28B 159B 2.31B 15.71B 6.13B 79.75B 6.23B 6.1B 264B EV / Sales 2026 *
398x
EV / Sales 2027 * 158x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+4.24%
1 week+8.45%
Current month-8.58%
1 month-3.58%
3 months-1.91%
6 months+20.21%
Current year+12.77%
1 week 51.6
Extreme 51.6
80.3
1 month 50.8
Extreme 50.8
80.3
Current year 38
Extreme 38
80.3
1 year 38
Extreme 38
80.3
3 years 16
Extreme 16
86.4
5 years 15.4
Extreme 15.4
122
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 2014-12-31
Director of Finance/CFO 48 2019-12-31
Corporate Officer/Principal 69 -
Director TitleAgeSince
Chairman 67 2019-12-31
Director/Board Member 62 2019-12-31
Director/Board Member 71 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
9/24/25 Sell

Chief Financial Officer

16,700 0.0287%
9/24/25 Sell

Chief Financial Officer

17,100 0.0294%
9/24/25 Sell

Chief Financial Officer

29,500 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+4.24%+8.45%-24.36%+131.08% 1.69B
+0.44%-0.56%+29.36%+30.75% 12.81B
-0.73%+1.75%+19.17%+33.90% 7.03B
-1.96%+4.36%+53.35%+47.77% 6.75B
+1.34%+1.49% - - 5.74B
-1.02%+20.98%-7.22%+79.99% 5.46B
-3.05%-3.63%-30.58%-24.96% 3.78B
-3.77%+0.88%+43.58%-45.10% 1.99B
-2.10%-7.62%+44.08%-11.01% 1.58B
+2.57%+5.22%-5.36%+15.55% 1.32B
Average -0.40%+3.34%+13.56%+28.66% 4.82B
Weighted average by Cap. -0.46%+3.43%+19.43%+33.75%

Financials

2026 *2027 *
Net sales 3.57M 4.17M 3.34M 3.06M 5.74M 399M 5.81M 39.46M 15.39M 200M 15.65M 15.31M 662M 9.14M 10.68M 8.56M 7.83M 14.7M 1.02B 14.89M 101M 39.42M 513M 40.09M 39.21M 1.7B
Net income -22.17M -25.88M -20.74M -18.99M -35.63M -2.48B -36.1M -245M -95.56M -1.24B -97.17M -95.06M -4.11B -25.65M -29.95M -24M -21.97M -41.24M -2.87B -41.78M -284M -111M -1.44B -112M -110M -4.76B
Net Debt -26.74M -31.22M -25.02M -22.9M -42.98M -2.99B -43.55M -296M -115M -1.5B -117M -115M -4.96B -308K -360K -288K -264K -495K -34.42M -502K -3.41M -1.33M -17.29M -1.35M -1.32M -57.19M
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
-
Date Price Change Volume
26-08-21 SEK 56.50 +4.24% 1,845,132
26-08-20 SEK 54.20 +1.31% 89,246
26-08-19 SEK 53.50 -2.73% 35,233
26-08-18 SEK 55.00 +6.38% 47,825
26-08-17 SEK 51.70 -0.77% 27,406
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
5.111EUR
Average target price
6.725EUR
Spread / Average Target
+31.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMP A SDB Stock